# Trade Mark Journal No.2025/045 7 November 2025

## WO0000001882579 (5,10)

Office of origin: United States of America

Date of International Registration:8 May 2025
Date of designation in the UK: 8 May 2025

International priority date claimed: 8 November 2024 (United States of America) (98844592)

Class 5
  Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in treating anesthetic and drug toxicity; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in resuscitating patients; medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and set for administering lipid emulsion to patients for medical purposes, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients.
Class 10
  An empty medical syringe.

ResQ Pharma, Inc.

Representative: Hillary E. Maynard Polsinelli PC, PO Box 140310, Kansas City MO 64114-0310, UNITED STATES OF AMERICA